Effect of nitric oxide synthesis modification on renal function in gentamicin-induced nephrotoxicity

Environmental Toxicology and Pharmacology

Volumn 3, Issue 2, 1997, Pages 123-128

  Valdivielso, J M ^a   Rivas Cabanero L ^a   Perez Barriocanal F ^a   Lopez Novoa J M ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Clearance; Gentamicin; L arginine; L NAME

Indexed keywords

ALKALINE PHOSPHATASE; ARGININE; GENTAMICIN; N ACETYL BETA GLUCOSAMINIDASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0342275260     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(97)00148-8     Document Type: Article

References (39)

1. Appel, G.B. and H.C. Neu, 1977, The nephrotoxicity of antimicrobial agents, New Engl. J. Med. 269, 663.
2. Baylis, C., P. Harton and K. Engels, 1990, Endothelial-derived relaxing factor controls renal hemodynamics in the normal rat kidney, J. Am. Soc. Nephrol. 1, 875.
3. Baylis, C., H.G. Rennke and B.M. Brenner, 1977, Mechanisms of the defect in glomerular ultrafiltration associated with gentamicin administration, Kidney Int. 12, 344.
4. Bonsnes, R.W. and H.A. Tausski, 1945, The colorimetric determination of creatinine of the Jaffé reaction, J. Biol. Chem. 158, 581-584.
5. Bretaudiere, J.P. and T. Spillman, 1984, Alkaline phosphatases, in: Methods in Enzymatic Analysis, 3rd edn, ed. H.U. Bergmeyer (Verlag Chemie, Weinheim) p. 75.
6. Brown, S.A., K. Sugimoto, G.G. Smith and F.B. Garry, 1988, Improved sodium hydroxide digestion method without homogenization for extraction of gentamicin from renal tissue, Antimicrob. Agents. Chemother. 32, 595.
7. Cleeter, M.W., J.M. Cooper, V.M. Darley-Usmar, S. Moncada and A.H.W. Schapira, 1994, Reversible inhibition of cytochrome c oxidase, the terminal enzyme of mitochondrial respiratory chain, by nitric oxide, FEBS Lett. 345, 50.
8. Deng, A. and C. Baylis, 1993, Locally produced EDRF controls preglomerular resistance and ultrafiltration coefficient, Am. J. Physiol. 246, F212.
9. Diamond, J.R., I. Pesek, S. Ruggieri and M.J. Karnovsky, 1989, Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury, Am. J. Physiol. 257, F798.
10. Gibey, R.R., J.L. Dupond, D. Alber, R.L. Des Floris and J.C. Henry, 1981, Predictive value of urinary N-acetyl-β -D-glucosaminidase (NAG), alanine aminopeptidase and β-2-microglobulin in evaluating nephrotoxicity of gentamicin, Clin. Chim. Acta. 116, 25.
11. Hibbs, J.B., R.R. Taintor and Z. Vaurin, 1989, Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-Arginine: a molecular mechanism regulating cell proliferation that targets intracellular iron, in: Nitric Oxide from L-Arginine: a Bioregulatory System, eds. S. Moncada and E.A. Higgs (Excepta Medica, Amsterdam) p. 189.
12. Ignarro, L.J., 1980, Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein, Circ. Res. 65, 1.
13. Katoh, T., K. Takahashi, K. Badr, S, Klahr and A.A. Reyes, 1994, Dietary supplementation with L-arginine ammeliorates glomerular hypertension in rats with subtotal nephrectomy, J. Am. Soc. Nephrol. 4, 1690.
14. Katsuki, S., W. Arnold, C. Mittal and F. Murad, 1977, Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine, J. Cyclic Nucleotide Res. 3, 23.
15. King, A.J., P. Mercer, J.L. Troy and B.M. Brenner, 1991, Endothelium-derived relaxing factor and the vascular reply to systemic hypertension, J. Am. Soc. Nephrol. 2, 1072.
16. Lahera, V., M.G. Salom, M.J. Fisken-Olsen and J.C. Romero, 1991a, Mediatory role of endothelium-derived nitric oxide in renal vasodilatory and excretory effects of bradikinin, Am. J. Hypertens. 4, 260.
17. Lahera, V., M.G. Salom, F. Miranda, S. Moncada and J.C. Romero, 1991b, Effects of N-nitro-L-arginine methyl esther on renal function and blood pressure, Am. J. Physiol. 261, F1033.
18. Maree A., G. Peer, D. Schwartz, I. Serban, M. Blum, Y. Wollmam, S. Cabili and A. Iaina, 1994, Role of nitric oxide in glycerol-induced acute renal failure in rats, Nephrol. Dial. Transplant. 9, 78.
19. G-nitro-arginine inhibits endothelium-dependent vasodilatation in the rabbit aorta and perfused rat mesentery (Abstract), Br. J. Pharmacol. 98, 905.
20. Palmer, R.M.J., D.S. Ashton and S. Moncada, 1988, Vascular endothelial cells synthesize nitric oxide from L-arginine, Nature (London) 333, 664.
21. Rees, D.D., R.M.J. Palmer, H.F. Hodson and S. Moncada, 1989, A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation, Br. J. Pharmacol. 96, 418.
22. Reyes, A.A., I.E. Karl and S. Klahr, 1994b, Role of arginine in health and in renal disease, Am. J. Physiol. 267, F331.
23. Reyes, A.A., D. Martin, S. Settle and S. Klahr, 1992, EDRF role in renal function and blood pressure of normal rats and rats with obstructive nephropathy, Kidney Int. 41, 403.
24. Reyes, A.A., B.H. Porras, F.I. Chasalow and S. Klahr, 1994a, Administration of L-arginine decreases the infiltration of the kidney by macrophagues in obstructive nephropathy and puromycin-induced nephrosis, Kidney Int. 45, 1346.
25. Rivas-Cabañero, L., A. Montero and J.M. López-Novoa, 1994, Increased glomerular nitric oxide synthesis in gentamicin-induced acute renal failure, Eur. J. Pharmacol. Environ. Toxicol. Pharmacol. 270, 119.
26. G-nitro-L-arginine methyl ester on gentamicin-induced nephrotoxicity in rats, Nephron 17, 203.
27. Robinson, D. and R. Thorpe, 1974, Fluorescent assay of alpha-L-fucosidase, Clin. Chim. Acta 55, 65.
28. Rodriguez-Barbero, A., E. Bosque, L. Rivas-Cabañero, M. Arévalo and J.M. López-Novoa, 1992, Effect of platelet activating factor antagonist treatment on gentamicin nephrotoxicity, Mediators Inflamm. 1, 23.
29. Rodríguez-Barbero, A., A.M. Rodríguez-López, R. Gonzalez- Sarmiento and J.M. López-Novoa, 1995, Gentamicin activates cultured rats mesangial cells. A role for patelet activating factor, Kidney Int. 47, 1346.
30. Salom, M.J., V. Lahera and J.C. Romero, 1991, Role of prostaglandins and endothelium-derived relaxing factor on the renal response to acethylcholine, Am. J. Physiol. 260, F145.
31. Schor, N., I. Ichikawa, H.G. Rennke, J.L. Troy and B.M. Brenner, 1981, Pathophysiology of altered glomerular function in amino-glycoside treated rats, Kidney Int. 19, 288.
32. Schramm, L., E. Heidbreder, K. Lopau, J. Schaar, D. De Cicco, R Götz and A. Heidland, 1994, Toxic acute renal failure in the rat: effects of L-Arginine and N-methyl-L-Arginine on renal function, Nephrol. Dial. Transplant. 9, 88.
33. Schultz, K.D., K. Schultz and G. Schultz, 1977, Sodium nitroprusside and other smooth muscle relaxants increase cyclic GMP in rats ductus deferens, Nature 265, 750.
34. Tolins, J.P., P.J. Shultz, L. Raij, 1991, Role of endothelium-derived relaxing factor in regulation of vascular tone and remodeling: Update of humoral regulation of vascular tone, Hypertension 17, 909.
35. Tolins, J.P., P.J. Shultz, L. Raij, D.M. Brown and S.M. Mauer, 1993, Abnormal renal haemodynamics responses to reduced renal perfusion pressure in diabetics rats: role of NO, Am. J. Physiol. 265, F886.
36. Verstrepen, W.A., E.J. Nouwen, X.S. Yue and M.E. De Broe, 1993, Altered expresion during toxic proximal tubular necrosis and regeneration, Kidney Int. 43, 1267.
37. Walder, C.E., C. Thiemermann and J.R. Vane, 1991, The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the rat, Br. J. Pharmacol. 102, 967.
38. Welch, W.J., C.S. Wilcox, K. Aisaka, S.S. Gross, O.W. Griffith, B.M. A. Fontoura, T. Maack and R. Levi, 1991, Nitric oxide synthesis from L-arginine modulates renal vascular resistance in isolated perfused and intact rat kidneys, J. Cardiovasc. Pharmacol. 17(Suppl. 37), S165.
39. Zatz, R. and G. De Nucci, 1991, Effects of acute nitric oxide inhibition on rat glomerular microcirculation, Am. J. Physiol. 261, F360.